RS50433B - Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika - Google Patents

Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika

Info

Publication number
RS50433B
RS50433B YUP-132/02A YUP13202A RS50433B RS 50433 B RS50433 B RS 50433B YU P13202 A YUP13202 A YU P13202A RS 50433 B RS50433 B RS 50433B
Authority
RS
Serbia
Prior art keywords
clusters
telithrokycin
spherical
preparation
production
Prior art date
Application number
YUP-132/02A
Other languages
English (en)
Inventor
Jean-Yves Godard
Valérie ROGNON-RAVAUX
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50433(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of YU13202A publication Critical patent/YU13202A/sh
Publication of RS50433B publication Critical patent/RS50433B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Postupak za dobijanje sfernih klastera telitromicina, naznačen time, što je pripremljena suspenzija kristala telitromicina, pa se zatim kristali oblažu fazom koja je nerastvoma u telitromicinu, a koja postepeno kristališe. Prijava sadrži 4 patentna zahteva.
YUP-132/02A 1999-08-26 2000-08-28 Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika RS50433B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
YU13202A YU13202A (sh) 2004-09-03
RS50433B true RS50433B (sr) 2009-12-31

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-132/02A RS50433B (sr) 1999-08-26 2000-08-28 Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika

Country Status (34)

Country Link
US (1) US6825218B1 (sr)
EP (1) EP1212336B1 (sr)
JP (1) JP4871467B2 (sr)
KR (1) KR100718222B1 (sr)
CN (1) CN1183151C (sr)
AR (1) AR025398A1 (sr)
AT (1) ATE255590T1 (sr)
AU (1) AU774385B2 (sr)
BR (1) BR0013569B1 (sr)
CA (1) CA2382497C (sr)
CO (1) CO5190666A1 (sr)
CZ (1) CZ2002594A3 (sr)
DE (1) DE60006976T2 (sr)
DK (1) DK1212336T3 (sr)
EA (1) EA005080B1 (sr)
ES (1) ES2209970T3 (sr)
FR (1) FR2797875B1 (sr)
HK (1) HK1049167B (sr)
HR (1) HRP20020167B1 (sr)
HU (1) HU229075B1 (sr)
IL (2) IL148128A0 (sr)
ME (2) ME00112B (sr)
MX (1) MXPA02001988A (sr)
NO (1) NO322622B1 (sr)
PL (1) PL204100B1 (sr)
PT (1) PT1212336E (sr)
RS (1) RS50433B (sr)
SI (1) SI1212336T1 (sr)
SK (1) SK287588B6 (sr)
TR (1) TR200200506T2 (sr)
TW (1) TWI272949B (sr)
UA (1) UA73523C2 (sr)
WO (1) WO2001014393A2 (sr)
ZA (1) ZA200201599B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
CA2492874C (en) * 2002-07-19 2011-09-20 Aventis Pharma S.A. Taste masked oral composition of telithromycin
JP5154078B2 (ja) * 2003-02-21 2013-02-27 ザ ユニヴァーシティ オブ バース 粒子の製造プロセス
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AU774385B2 (en) 2004-06-24
PT1212336E (pt) 2004-04-30
EP1212336A2 (fr) 2002-06-12
AR025398A1 (es) 2002-11-27
PL353137A1 (en) 2003-10-20
FR2797875B1 (fr) 2001-10-19
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
CN1371386A (zh) 2002-09-25
ATE255590T1 (de) 2003-12-15
DE60006976D1 (de) 2004-01-15
TWI272949B (en) 2007-02-11
JP2003507484A (ja) 2003-02-25
BR0013569B1 (pt) 2014-02-25
CA2382497A1 (fr) 2001-03-01
NO20020926D0 (no) 2002-02-26
DK1212336T3 (da) 2004-03-15
YU13202A (sh) 2004-09-03
EP1212336B1 (fr) 2003-12-03
DE60006976T2 (de) 2004-10-21
MXPA02001988A (es) 2002-08-20
EA005080B1 (ru) 2004-10-28
HU229075B1 (hu) 2013-07-29
CN1183151C (zh) 2005-01-05
NO20020926L (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
UA73523C2 (uk) 2005-08-15
EA200200294A1 (ru) 2002-08-29
HK1049167B (zh) 2005-08-19
MEP20108A (en) 2010-06-10
CO5190666A1 (es) 2002-08-29
ES2209970T3 (es) 2004-07-01
SI1212336T1 (en) 2004-04-30
WO2001014393A3 (fr) 2001-06-21
US6825218B1 (en) 2004-11-30
KR20020033771A (ko) 2002-05-07
BR0013569A (pt) 2002-05-14
SK2532002A3 (en) 2002-09-10
CA2382497C (fr) 2011-06-28
NO322622B1 (no) 2006-11-06
ME00112B (me) 2010-10-10
SK287588B6 (sk) 2011-03-04
FR2797875A1 (fr) 2001-03-02
KR100718222B1 (ko) 2007-05-15
TR200200506T2 (tr) 2002-08-21
JP4871467B2 (ja) 2012-02-08
HRP20020167B1 (en) 2006-06-30
WO2001014393A2 (fr) 2001-03-01
CZ2002594A3 (cs) 2002-09-11
IL148128A0 (en) 2002-09-12
HUP0202842A3 (en) 2003-03-28
HUP0202842A2 (hu) 2003-01-28
IL148128A (en) 2006-10-31
HK1049167A1 (en) 2003-05-02
HRP20020167A2 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
NO863997D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
RS50433B (sr) Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika
MY148475A (en) Controlled release preparations comprising tramadol and topiramate
HUP0000944A2 (hu) A 2-amino-4-(4-fluor-benzilamino)-1-etoxikarbonil-aminobenzol új módosulatai és eljárás előállításukra
AU3028897A (en) New guanidine derivatives, methods of preparing them, and their use as drugs
SE9804003D0 (sv) A method of producing drug particles
HUP0401201A3 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
HUP9901616A3 (en) Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same
EP0717992A3 (en) Aqueous suspension formulations for pharmaceutical applications
NO20004919D0 (no) FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
BR0014671A (pt) Método para a produção de substâncias proteináceas
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
NO20021368L (no) Fremgangsmåte for fremstilling av fenyleddiksyre derivater
AU5160599A (en) Method for the production of n,n'-carbonyl diazoles
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives
NO932044D0 (no) Funksjonaliserte, vinylazolholdige, farmasoeytiske preparater, anvendelse av disse vinylazoler for fremstilling av legemidler, vinylazoler i seg selv, saavel som fremgangsmaater for deres fremstilling
AU5068700A (en) Ceramic material to be utilized in the field of medicine, use of the same, and method for the production thereof
EA200100317A1 (ru) Новые производные бензоилгуанидина с эффективными свойствами, способ их получения и их применение при изготовлении лекарственных средств
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
EP0396080A3 (en) New serine derivatives, process for their preparation and their use in human therapy
WO2002044346A3 (de) Stammzellen, verfahren zu deren expansion in vitro sowie deren verwendung
HUP0202098A2 (en) Use of 2-aminotetralin derivatives for production of pharmaceutical composition for the therapy of glaucoma